Core Viewpoint - Concrete Pumping Holdings, Inc. is discussing its financial results for the second quarter ended April 30, 2025, during a conference call with key executives present [2][3]. Company Overview - The conference call features CEO Bruce Young, CFO Iain Humphries, and External Director of Investor Relations Cody Slach [3]. - The company emphasizes the importance of understanding its operations through forward-looking statements, which are subject to various risks and uncertainties [4]. Financial Reporting - The call will reference non-GAAP financial measures such as adjusted EBITDA, net debt, and free cash flow, which are considered useful for investors [6].

Financial Performance - First quarter 2025 revenue decreased by 5% to $1089.6 million compared to $1143.9 million in the first quarter of 2024[40] - Comparable sales decreased by 3% compared to an increase of 7% in the prior year[24, 38] - The company reported an operating loss of $68 million[24] - Gross margin decreased to 29.6% from 40.6% in the prior year[38] - Net loss was $(64.9) million, or $(0.36) per diluted share[41] - Ending inventory decreased by 5% to $645.1 million compared to $681.1 million in the prior year[37] Brand Performance - American Eagle brand revenue decreased by 4% to $693.9 million[40] - Aerie brand revenue decreased by 3% to $359.8 million[40] Guidance - Second quarter 2025 operating income is expected to be $40 million to $45 million[32] - Second quarter 2025 comparable sales are expected to be down 3%[32]

Group 1 - The conference call is for Kohl's Corporation's First Quarter 2025 earnings, indicating a focus on financial performance and future initiatives [1] - Trevor Novotny, Senior Manager of Investor Relations, is leading the call, suggesting a structured approach to investor communication [1] - The call includes a question-and-answer session, highlighting engagement with analysts and investors [1] Group 2 - Forward-looking statements regarding projected financial results and future initiatives are made, which are subject to risks and uncertainties [2] - The company emphasizes that actual results may differ materially from projections due to various risks outlined in their annual report [2] - Non-GAAP financial measures may be referenced during the call, indicating a focus on alternative financial metrics for analysis [3]

Q1 Results Presentation May 29, 2025 1 Cautionary Statement Regarding Forward-Looking Information This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. The Company intends forward-looking terminology such as "believes," "expects," "may," "will," "should," "anticipates," "plans," or similar expressions to identify forward-looking statements. Forward-looking statements include, but are not limited to, statements regarding our 2025 a ...

Core Viewpoint - Abercrombie & Fitch Co. reported record first quarter net sales of $1.1 billion, reflecting an 8% increase compared to the previous year, driven by broad-based growth across regions, particularly from Hollister brands which saw a 22% increase in sales [2][5][6] Financial Performance - Net sales for the first quarter ended May 3, 2025, were $1,097,311,000, up from $1,020,730,000 in the same quarter of 2024, marking an 8% increase [4][6][7] - Operating income decreased to $101,533,000, down from $129,849,000 year-over-year, resulting in an operating margin of 9.3%, down from 12.7% [6][24] - Net income attributable to Abercrombie & Fitch was $80,413,000, compared to $113,850,000 in the prior year, with diluted earnings per share at $1.59, down from $2.14 [6][24] Segment Performance - Net sales by segment showed the following growth: Americas up 7% to $874,804,000, EMEA up 12% to $185,036,000, and APAC up 5% to $37,471,000 [4][5] - Brand performance indicated Hollister brands grew by 22% while Abercrombie brands saw a decline of 4% [2][5][7] Cash Flow and Capital Allocation - The company repurchased 2.6 million shares for approximately $200 million, representing a 5% reduction in shares outstanding [2][9] - As of May 3, 2025, the company had cash and equivalents of $511 million, down from $864 million a year prior, with total liquidity of approximately $940 million [11][9] Outlook - For the second quarter, the company expects net sales growth in the range of 3% to 5%, with an operating margin projected between 12% and 13% [12][17] - The full-year outlook anticipates net sales growth of 3% to 6% and net income per diluted share in the range of $9.50 to $10.50 [17]

Financial Data and Key Metrics Changes - Total revenues for Q1 2025 were $8,600,000, representing a 9% increase from the same period last year [5][12] - Net loss for Q1 2025 was $4,200,000 or $0.47 per share, compared to a net loss of $10,400,000 or $2.88 per share for the prior year [15] - Adjusted EBITDA decreased from $4,600,000 in Q1 2024 to $4,400,000 in Q1 2025 [15][16] Business Line Data and Key Metrics Changes - Ameluz sales increased by $500,000 due to a higher unit price and the launch of the RotoLED XL lamp, which generated $200,000 in sales [12] - Total operating expenses decreased to $13,100,000 in Q1 2025 from $13,400,000 in Q1 2024 [12][13] - Cost of revenues decreased by $900,000 or 22.1% compared to last year, attributed to a reduced cost structure under the Ameluz license [13] Market Data and Key Metrics Changes - The company achieved a significant milestone with the granting of a patent for a new formulation of Ameluz, providing protection until December 2043 [6][7] - The enrollment of the final patient in the Phase three clinical trial for Ameluz was announced, aiming to extend the label for treatment beyond the face and scalp [8] Company Strategy and Development Direction - The company aims to achieve record revenues in 2025 without increasing costs, supported by past investments and sales force effectiveness [5] - Future goals include expanding Ameluz's applications to treat superficial basal cell carcinoma and moderate to severe acne, addressing significant medical needs [9][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving breakeven as quickly as possible, highlighting improved gross profit and reduced operating expenses [11] - The company is committed to exploring additional applications for Ameluz beyond actinic keratosis, indicating a proactive approach to growth [9] Other Important Information - Cash and cash equivalents as of March 31, 2025, were $1,800,000, down from $5,900,000 as of December 31, 2024 [16] - Inventory on hand was $6,500,000 compared to $6,600,000 as of December 31, 2024 [16] Q&A Session Summary Question: How many LAMP units were sold in Q1 2025? - The company placed 18 XL lamps in Q1 2025 [19][20] Question: Is there any sales force attrition affecting expenses? - There has been some turnover, but the company is committed to reorganizing the team for efficiency [24] Question: What is the status of reimbursement for the three-tube indication? - The company has ensured that Medicare covers the three-tube indication, with no reported refusals from doctors [29]

Core Viewpoint - Ondas Holdings Inc. is conducting its Q1 2025 earnings conference call, indicating a focus on financial performance and strategic direction for the upcoming quarter [1]. Company Participants - The call features key executives including Eric Brock (Chairman, President, and CEO), Neil Laird (Interim CFO), Oshri Lugassy (Co-CEO, Autonomous Systems), and Markus Nottelmann (CEO, Ondas Networks) [1]. Conference Call Structure - The conference call is structured to allow participants to listen only, with an emphasis on forward-looking statements that may contain risks and uncertainties [2]. - The company has provided a reconciliation of non-GAAP financial measures to GAAP measures, highlighting the importance of these metrics for understanding business trends [3].

Financial Data and Key Metrics Changes - Total revenue for the first quarter of 2025 was $13.6 million, down $3.8 million or 22% year over year [11] - Gross profit decreased by $2.9 million or 25% to $8.8 million, with gross margin at 64.2% compared to 66.6% in the same quarter of the previous year [13][14] - Net loss attributable to stockholders was $12.4 million or $17.44 per share, compared to a net loss of $9.8 million or $16.91 per share in the first quarter of 2024 [15] - Adjusted EBITDA loss for the first quarter was $8.3 million, compared to a loss of $5.1 million in the prior year [15] - Cash and cash equivalents as of March 31, 2025, were $3.2 million, with total debt obligations reduced to approximately $35.5 million [16][17] Business Line Data and Key Metrics Changes - Systems revenue decreased by 25%, with a 25% decrease in lease systems revenue as well [12] - The percentage of total systems revenue from internal lease programs was approximately 25%, unchanged from the prior year [12] Market Data and Key Metrics Changes - International revenue decreased by 29%, while U.S. revenue decreased by 16.5% year over year [12] - The global capital equipment environment remains uncertain, affecting customer system adoption in both U.S. and international markets [6][8] Company Strategy and Development Direction - The company is focusing on transitioning to higher quality cash revenues, with cash system sales in the U.S. representing 80% of total U.S. system sales [7] - Plans to evolve the portfolio and launch a new body device in the second half of 2025 are underway [9] - The company is managing cash burn through disciplined cost management and targeted investments for long-term growth [9] Management's Comments on Operating Environment and Future Outlook - Management noted that customer financing pressures, economic uncertainty, and tighter credit markets are impacting system adoption [6] - The company does not provide full-year 2025 financial guidance but expects sequential revenue growth in the second quarter [18] Other Important Information - The company enhanced its balance sheet by converting $11 million of debt to equity and secured a new bridge loan amendment [10][17] - The company is actively evaluating strategic alternatives to maximize shareholder value amid current market conditions [18] Q&A Session Summary Question: Impact of tariffs on international business - Management indicated that a 10% tariff on products sourced from Israel could impact gross margins by 11.5% in 2025 and 22.5% in 2026, but the overall impact is expected to be modest and manageable through pricing [20][22][24] Question: Timing of delayed sales contracts - Delays in closing sales contracts were attributed to economic hesitancy affecting both U.S. sales and international distributor orders [27][29] Question: Update on next-gen body contouring device - The launch of the next-gen body contouring device is expected in the early part of the second half of 2025, with significant market uptake anticipated based on customer feedback [30][31][32]

Core Viewpoint - Gauzy Ltd. is conducting its Q1 2025 earnings conference call, indicating a focus on financial performance and future projections [1]. Group 1: Company Overview - The conference call is hosted by Gauzy's CEO Eyal Peso and CFO Meir Peleg, highlighting the leadership's involvement in discussing the company's performance [3]. - The call is recorded and allocated one hour for prepared remarks and Q&A, suggesting a structured approach to investor communication [1]. Group 2: Financial Statements and Projections - Management will be making forward-looking statements based on current expectations and beliefs, which are inherently uncertain [3]. - Actual results may differ materially from forward-looking statements due to various risks and uncertainties discussed in the earnings news release [4].

Financial Data and Key Metrics Changes - For Q1 2025, net revenue was $15.4 million, a decline of 24% from $20.2 million in Q1 2024, primarily due to SKU rationalization and reduced consumer demand [7][26] - Adjusted EBITDA loss slightly improved to $2.5 million from $2.6 million year-over-year, despite a 24% sales reduction [7][29] - Gross margin decreased to 61.4% from 65.1% in the previous year, attributed to product mix changes [27] - Operating loss narrowed to $3.7 million from $5.3 million in the year-ago quarter, an improvement of approximately 30% [28][29] - Net loss for Q1 2025 was $3.9 million, improving by approximately 25% from a loss of $5.2 million in Q1 2024 [29] Business Line Data and Key Metrics Changes - The company launched one new product category in Q1 2025, while suspending new product launches from Asia for the year [26] - Launch revenue was $400,000 in both Q1 2025 and Q1 2024 [26] Market Data and Key Metrics Changes - The company experienced softness in consumer demand, particularly in the latter part of the quarter, which was compounded by reduced Amazon traffic due to changes in its affiliate program [7][8] - Inventory levels increased to $18.1 million from $13.7 million at the end of Q4 2024, reflecting a buildup in anticipation of demand for seasonal products [30] Company Strategy and Development Direction - The company is focusing on four strategic initiatives: accelerating manufacturing diversification, expanding into consumables, implementing strategic pricing adjustments, and reducing fixed costs [10][21] - The goal is to manufacture no more than 30% of goods in China by the end of 2025, accelerating the previous target of below 40% by 2026 [12] - The company has paused its share repurchase program to conserve cash amid the current macroeconomic environment [18] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating the current volatility without raising equity capital in 2025, despite withdrawing guidance for the year due to uncertainty [19][31] - The company believes that the actions taken now will set the foundation for a return to growth and profitability beyond 2025 [32] - Management acknowledged the challenges posed by the tariff environment but emphasized the importance of agility and resilience in their strategy [9][20] Other Important Information - The company is targeting annualized savings of $5 million to $6 million through fixed cost reduction initiatives, with approximately $4 million expected from headcount reductions [16][25] - Cash preservation remains a priority, with cash levels at approximately $14.3 million as of March 31, 2025 [30] Q&A Session Summary Question: Can you talk about your inventory plans in the near and medium term given the 30% China tariffs? - Management indicated that they have been proactive in managing inventory and have not rushed to bring in products from China, focusing instead on securing stable supply chains [35][36] Question: Can you elaborate on your pricing strategy and consumer reactions? - Management noted that the pricing strategy has led to mixed results, with some products experiencing decreased velocity due to price increases, but overall positioning remains strong [41][42] Question: Is there a way to speed up your diversification strategy in manufacturing? - Management committed to accelerating the diversification strategy as quickly as possible while maintaining product quality [45] Question: Will the company be paying any dividends in the future? - Management stated that cash conservation is a priority due to restructuring plans and the current macroeconomic environment, focusing on long-term growth instead [49] Question: Would management consider revising its policy on granting employee stock options? - Management affirmed that stock options are a tool for incentivizing performance and aligning interests with shareholders, and they will continue to evaluate this policy [52][54]